FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569367256> ?p ?o ?g. }

• W1569367256 endingPage "241" @default.
• W1569367256 startingPage "233" @default.
• W1569367256 abstract "Brochstein JA, Grupp S, Yang H, Pillemer SR, Geba GP. Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host disease.Pediatr Transplantation 2010:14:233–241. © 2009 John Wiley & Sons A/S. Abstract: In a phase-1 study, siplizumab, a humanized anti-CD2 monoclonal antibody, was administered (0.012 or 0.04 mg/kg) to 10 pediatric patients with ≥ grade-II newly diagnosed, non-steroid-refractory aGvHD after BMT or PBSCT. SAEs and other AEs including infections, and GvHD staging changes (overall, skin, liver, gut) were evaluated over 364 days. Patients reported a total of 121 AEs (19 grade-3, 5 grade-4 0.012 mg/kg group; 17 grade-3, 17 grade-4 0.04 mg/kg group) and 14 SAEs (five grade-3, three grade-4, 0.012 mg/kg group; three grade-3, 0.04 mg/kg group); 15 AEs in five patients and four SAEs in three patients (fever, PTLD, adenoviral infection, and EBV lymphoma) were considered siplizumab-related. Six deaths occurred (study days 17–267); two were considered siplizumab-related: one from EBV-associated PTLD (0.012 mg/kg) and one from adenoviral infection (0.04 mg/kg); the other four deaths could potentially be attributed in part to study drug Three patients (one, 0.012 mg/kg group; two, 0.04 mg/kg group) developed PTLD. By study day 12, GvHD grade decreased in 3/5 and 2/5 patients in the 0.012 and 0.04 mg/kg groups, respectively; remission (grade 0) occurred in one patient in each group. Four of five patients (0.012 mg/kg group) and one of four patients (0.04 mg/kg group) achieved grade 0 GvHD during the first 100 study days (55.6% response). While treatment with siplizumab was associated with improvement of GvHD and remission in some pediatric patients, the overall high morbidity, mortality, and occurrence of PTLD is of safety concern, not warranting further development of siplizumab for the treatment of aGvHD in children." @default.
• W1569367256 created "2016-06-24" @default.
• W1569367256 creator A5010096299 @default.
• W1569367256 creator A5020601958 @default.
• W1569367256 creator A5036684928 @default.
• W1569367256 creator A5059837134 @default.
• W1569367256 creator A5077440294 @default.
• W1569367256 date "2009-08-11" @default.
• W1569367256 modified "2023-09-26" @default.
• W1569367256 title "Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host disease" @default.
• W1569367256 cites W1500757144 @default.
• W1569367256 cites W193514409 @default.
• W1569367256 cites W1979982461 @default.
• W1569367256 cites W1996389468 @default.
• W1569367256 cites W1997145514 @default.
• W1569367256 cites W2002595904 @default.
• W1569367256 cites W2003272849 @default.
• W1569367256 cites W2003388579 @default.
• W1569367256 cites W2007408185 @default.
• W1569367256 cites W2008201186 @default.
• W1569367256 cites W2012891748 @default.
• W1569367256 cites W2023577808 @default.
• W1569367256 cites W2023944457 @default.
• W1569367256 cites W2026509045 @default.
• W1569367256 cites W2032086303 @default.
• W1569367256 cites W2034325365 @default.
• W1569367256 cites W2037326574 @default.
• W1569367256 cites W2072678626 @default.
• W1569367256 cites W2079980689 @default.
• W1569367256 cites W2084345572 @default.
• W1569367256 cites W2108215737 @default.
• W1569367256 cites W2115232902 @default.
• W1569367256 cites W2330678949 @default.
• W1569367256 cites W2395135053 @default.
• W1569367256 cites W2407208193 @default.
• W1569367256 cites W2897901681 @default.
• W1569367256 cites W33772365 @default.
• W1569367256 cites W4229844446 @default.
• W1569367256 cites W4236572065 @default.
• W1569367256 doi "https://doi.org/10.1111/j.1399-3046.2009.01223.x" @default.
• W1569367256 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19671093" @default.
• W1569367256 hasPublicationYear "2009" @default.
• W1569367256 type Work @default.
• W1569367256 sameAs 1569367256 @default.
• W1569367256 citedByCount "7" @default.
• W1569367256 countsByYear W15693672562012 @default.
• W1569367256 countsByYear W15693672562013 @default.
• W1569367256 countsByYear W15693672562016 @default.
• W1569367256 countsByYear W15693672562017 @default.
• W1569367256 crossrefType "journal-article" @default.
• W1569367256 hasAuthorship W1569367256A5010096299 @default.
• W1569367256 hasAuthorship W1569367256A5020601958 @default.
• W1569367256 hasAuthorship W1569367256A5036684928 @default.
• W1569367256 hasAuthorship W1569367256A5059837134 @default.
• W1569367256 hasAuthorship W1569367256A5077440294 @default.
• W1569367256 hasConcept C121332964 @default.
• W1569367256 hasConcept C126322002 @default.
• W1569367256 hasConcept C141071460 @default.
• W1569367256 hasConcept C142424586 @default.
• W1569367256 hasConcept C197934379 @default.
• W1569367256 hasConcept C2779338263 @default.
• W1569367256 hasConcept C2779972918 @default.
• W1569367256 hasConcept C2911091166 @default.
• W1569367256 hasConcept C71924100 @default.
• W1569367256 hasConcept C87355193 @default.
• W1569367256 hasConcept C90924648 @default.
• W1569367256 hasConceptScore W1569367256C121332964 @default.
• W1569367256 hasConceptScore W1569367256C126322002 @default.
• W1569367256 hasConceptScore W1569367256C141071460 @default.
• W1569367256 hasConceptScore W1569367256C142424586 @default.
• W1569367256 hasConceptScore W1569367256C197934379 @default.
• W1569367256 hasConceptScore W1569367256C2779338263 @default.
• W1569367256 hasConceptScore W1569367256C2779972918 @default.
• W1569367256 hasConceptScore W1569367256C2911091166 @default.
• W1569367256 hasConceptScore W1569367256C71924100 @default.
• W1569367256 hasConceptScore W1569367256C87355193 @default.
• W1569367256 hasConceptScore W1569367256C90924648 @default.
• W1569367256 hasIssue "2" @default.
• W1569367256 hasLocation W15693672561 @default.
• W1569367256 hasLocation W15693672562 @default.
• W1569367256 hasOpenAccess W1569367256 @default.
• W1569367256 hasPrimaryLocation W15693672561 @default.
• W1569367256 hasRelatedWork W2002120878 @default.
• W1569367256 hasRelatedWork W2003938723 @default.
• W1569367256 hasRelatedWork W2047967234 @default.
• W1569367256 hasRelatedWork W2118496982 @default.
• W1569367256 hasRelatedWork W2157982523 @default.
• W1569367256 hasRelatedWork W2351796763 @default.
• W1569367256 hasRelatedWork W2439875401 @default.
• W1569367256 hasRelatedWork W2528057197 @default.
• W1569367256 hasRelatedWork W3176439830 @default.
• W1569367256 hasRelatedWork W2525756941 @default.
• W1569367256 hasVolume "14" @default.
• W1569367256 isParatext "false" @default.
• W1569367256 isRetracted "false" @default.
• W1569367256 magId "1569367256" @default.
• W1569367256 workType "article" @default.